Literature DB >> 15690725

Comparisons of lesion detectability in ultrasound images acquired using time-shift compensation and spatial compounding.

James C Lacefield1, Wayne C Pilkington, Robert C Waag.   

Abstract

The effects of aberration, time-shift compensation, and spatial compounding on the discrimination of positive-contrast lesions in ultrasound b-scan images are investigated using a two-dimensional (2-D) array system and tissue-mimicking phantoms. Images were acquired within an 8.8 x 12-mm2 field of view centered on one of four statistically similar 4-mm diameter spherical lesions. Each lesion was imaged in four planes offset by successive 45 degree rotations about the central scan line. Images of the lesions were acquired using conventional geometric focusing through a water path, geometric focusing through a 35-mm thick distributed aberration phantom, and time-shift compensated transmit and receive focusing through the aberration phantom. The views of each lesion were averaged to form sets of water path, aberrated, and time-shift compensated 4:1 compound images and 16:1 compound images. The contrast ratio and detectability index of each image were computed to assess lesion differentiation. In the presence of aberration representative of breast or abdominal wall tissue, time-shift compensation provided statistically significant improvements of contrast ratio but did not consistently affect the detectability index, and spatial compounding significantly increased the detectability index but did not alter the contrast ratio. Time-shift compensation and spatial compounding thus provide complementary benefits to lesion detection.

Entities:  

Mesh:

Year:  2004        PMID: 15690725     DOI: 10.1109/tuffc.2004.1386682

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  1 in total

1.  3-D spatial compounding using a row-column array.

Authors:  Samer I Awad; Jesse T Yen
Journal:  Ultrason Imaging       Date:  2009-04       Impact factor: 1.578

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.